Table 4 Therapies targeting PI3K/Akt signaling

From: Targeting PI3K/Akt signal transduction for cancer therapy

Agent

Targets

Inhibitors

Apoptosis

p53

BKM120

CAL-101

GDC0068

p-S6

BYL719

GDC-0068

Rapamycin

p38

GSK2141795

Proliferation

p53

Bez235

Temsirolimus

p-S6

XL765

XL147

GSK2121183

LY2780301

Rapamycin

Deforolimus

CDK1

Everolimus

TGF-β1

Bez235

Autophagy

LC3B

MK2206

p-S6

AZD5363